See where the future
is built. Come home
with a decision.

Xcubed gives leaders in health, technology and finance trusted access to the world's innovation frontiers, in China, the US, India and beyond. We turn what you find there into strategy, partnerships and ventures you can act on.

We frame the question before you go, and translate what you see when you return.

Innovation no longer sits in one place. China leads in some technologies, the US in others, India in talent and scale. From the outside each frontier is hard to read accurately and harder to reach credibly. We close both gaps, wherever the answer lives.

How we work

Three moves, one outcome

An immersion is only worth the flights if something changes when your leaders get home. Our work sits either side of the visit.

i
Before

We frame the question

We sit with you to define the strategic question the visit must answer, and shape the itinerary around it.

ii
During

We open the right rooms

Curated access to the companies, labs and hospitals that matter to you, with us there to interpret in real time.

iii
After

We turn it into a decision

A written view, clear options and a board-ready case, so a memorable trip becomes a made decision.

Ways to work with us

How we work with you

Three shapes, depending on how far you want to go. Most begin with a briefing, then decide.

Start here

Strategic briefing

Days. Fixed fee.

We frame the question you are facing and map where the answer lives, in China, the US or India. You find out whether a visit is worth the flights, and what it should target.

You leave with A written point of view and a clear recommendation.
Core

Hosted immersion

About a week on the ground. Priced per person.

A curated visit to the companies, labs and institutions that matter to you, hosted and interpreted in real time, framed before you go and synthesised when you return.

You leave with Access, plus a board-ready view of what to do about it.
Ongoing

Retained advisory

Monthly. Scoped to the work.

We help you act on what you found: partner introductions, diligence, or standing up a venture or capability, with our people on both sides of the bridge.

You leave with Partnerships formed, deals progressed, or a venture built.

Pricing is scoped to each engagement. Start with a briefing and we shape the rest around your question.

Request a briefing
Where we work

Four worlds, one method

One relationship model across four worlds and every frontier, each led by people who belong in the room.

Health and pharma

Early-stage pipelines are moving fast, with China now originating a large share and the US still setting the commercial pace. We convene and interpret both as peers, not tourists.

Technology and robotics

Robotics, autonomous mobility and applied AI, seen where they are actually being built, from Shenzhen to the Bay Area to Bengaluru.

Payers and insurers

The cost, care and delivery reforms Western systems debate, running at national scale elsewhere, with the lessons that transfer.

Education and families

Safe, guided journeys that open young minds to the technology shaping their future, with parents welcome to join.

Three ways in

For leaders, families and the next generation

The same access and judgment, shaped for two different rooms.

For leaders

See the frontier. Come home with a decision.

Strategic briefings, hosted immersions and retained advisory for leaders in health, technology and finance, across China, the US and India.

Request a briefing
For families and students

The same access. A different room.

Innovation tours, hackathons and summer camps, showing the next generation where the future is being built.

Explore family journeys
For 18 to 30s

Frontier Cohort

A structured China immersion for postgraduates, young founders and gap-year students. Build something real, travel with a cohort, and come home with a plan.

Explore the Frontier Cohort
Perspectives

Why this matters now

A view of the shift, drawn from current, credible sources rather than assertion.

United States, AI capital
$285.9bn of private AI investment in 2025, about 83% of the global total.

The US still sets the pace on capital and commercialisation. If you want to read where AI money goes, you read America first.

Source: Stanford HAI AI Index 2026.
China, life sciences
Roughly a third of global pharma licensing value now comes from China.

Chinese drugmakers signed about $136bn in cross-border out-licensing in 2025, close to ten times the level of 2021.

Source: PharmCube, via Caixin Global, 2026.
India, talent and scale
More than 1,700 global capability centres run by multinationals, employing about 1.9m people.

India has moved from cost arbitrage to running product, R and D and AI for the world's largest companies.

Source: NASSCOM and Zinnov, 2025.

Access is no longer the edge. Judgment is.

We come from your world

Built by people with board-level experience inside a global health payer, and deep enterprise AI and data. We speak your language.

We sell the decision, not the trip

The immersion is the method. Our value is the framing before and the translation after, the part that does not commoditise.

Proven on the ground

Delivered programmes through world-leading innovators, with local partners in each market whose relationships are already built.

Start with a short briefing, shaped around the question you are actually facing.

Request a briefing